MGRX Relative Valuation
MGRX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MGRX is overvalued; if below, it's undervalued.
Historical Valuation
Mangoceuticals Inc (MGRX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Mangoceuticals Inc (MGRX) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price：1.17
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Mangoceuticals Inc. (MGRX) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
Mangoceuticals Inc. (MGRX) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
Mangoceuticals Inc. (MGRX) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Mangoceuticals Inc. (MGRX) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Mangoceuticals Inc. (MGRX) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Mangoceuticals Inc (MGRX) has a current Price-to-Book (P/B) ratio of 1.09. Compared to its 3-year average P/B ratio of 2.82 , the current P/B ratio is approximately -61.50% higher. Relative to its 5-year average P/B ratio of 2.82, the current P/B ratio is about -61.50% higher. Mangoceuticals Inc (MGRX) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -56.50%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -56.50% , the current FCF yield is about -100.00% lower.
1.04
P/B
Median3y
2.82
Median5y
2.82
-34.50
FCF Yield
Median3y
-56.50
Median5y
-56.50
Competitors Valuation Multiple
The average P/S ratio for MGRX's competitors is 0.00, providing a benchmark for relative valuation. Mangoceuticals Inc Corp (MGRX) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of -36.83%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MGRX decreased by 51.24% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -1.50K to -9.04K.
The secondary factor is the Revenue Growth, contributed -36.83%to the performance.
Overall, the performance of MGRX in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Mangoceuticals Inc (MGRX) currently overvalued or undervalued?
What is Mangoceuticals Inc (MGRX) fair value?
How does MGRX's valuation metrics compare to the industry average?
What is the current P/B ratio for Mangoceuticals Inc (MGRX) as of Dec 05 2025?
What is the current FCF Yield for Mangoceuticals Inc (MGRX) as of Dec 05 2025?
What is the current Forward P/E ratio for Mangoceuticals Inc (MGRX) as of Dec 05 2025?